Follow us on...
IconTwitterlinkedin





Search News Archives
Search for a Supplier

Company Name:


Location:

Product:

E-Newsletters
E Newsletter sign up
Calendar of events
«  »
SMTWTFS
 12345
6789101112
13141516171819
20212223242526
2728293031 
Social Media
twitter
Facebook
linkedin

DETERMINATION OF PACLITAXEL IN HUMAN PLASMA BY XLC-MS USING SYMBIOSIS™ PHARMA

publication date: Mar 21, 2010
 | 
author/source: Spark Holland B.V.
Download Print Send a summary of this page to someone via email.

The SymbiosisTM Pharma is Spark Holland's unique solution for integrated on-line SPE-LC-MS automation (XLCMS). The system offers large flexibility in processing different types of samples selecting one of the three fully automated operational modes: LC-MS, XLC-MS, or AMD (Advanced Method Development). A sensitive, specific, accurate and precise assay was developed for the on-line extraction and determination of paclitaxel in human plasma by XLC-MS, using the SymbiosisTM Pharma. This method was developed as part of an evaluation, to introduce this new technology into our bioanalytical laboratory. This application note demonstrates the ease of transfer of an off-line sample pretreatment to an on-line protocol, with a concomitant increase in productivity. Paclitaxel is a taxane diterpene amide that was first extracted from the Western yew, Taxus brevifolia. This compound has been shown to be effective in the treatment of a variety of human neoplastic diseases.

To view the full article please click here




blog comments powered by Disqus



Can't find what you are looking for?

Company Name:

Location:

Product:



Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have a product enquiry, please contact the supplier directly.


Lab Bulletin is published by newleaf marketing communications ltd
Lab Bulletin 2012 Media information Pack